4
Changes in Ownership
Aptevo Therapeutics Inc. Filed Acc 0001019056-21-000142
Options or other derivatives
- SVP & Chief Scientific Officer acquired 22,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Jane A SVP & Chief Scientific Officer | 2021-01-29 | Grant or award · Stock Option (right to buy) | +16,500 | 16,500 | D: show line 1 in the form | |||||
| Gross Jane A SVP & Chief Scientific Officer | 2021-01-29 | Grant or award · Restricted Stock Unit | +5,500 | 5,500 | D: show line 2 in the form |
Loading xslF345X03/gross.xml…